Observe Medical ASA Statistics
Total Valuation
OSL:OBSRV has a market cap or net worth of NOK 32.46 million. The enterprise value is 116.64 million.
Market Cap | 32.46M |
Enterprise Value | 116.64M |
Important Dates
The last earnings date was Tuesday, March 18, 2025.
Earnings Date | Mar 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
OSL:OBSRV has 19.26 million shares outstanding. The number of shares has increased by 297.36% in one year.
Current Share Class | n/a |
Shares Outstanding | 19.26M |
Shares Change (YoY) | +297.36% |
Shares Change (QoQ) | +40.17% |
Owned by Insiders (%) | 10.95% |
Owned by Institutions (%) | 1.81% |
Float | 5.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.39 |
PB Ratio | 1.35 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.93, with an EV/FCF ratio of -3.59.
EV / Earnings | -0.92 |
EV / Sales | 6.31 |
EV / EBITDA | 2.93 |
EV / EBIT | n/a |
EV / FCF | -3.59 |
Financial Position
The company has a current ratio of 0.20, with a Debt / Equity ratio of 3.57.
Current Ratio | 0.20 |
Quick Ratio | 0.11 |
Debt / Equity | 3.57 |
Debt / EBITDA | 2.17 |
Debt / FCF | -2.65 |
Interest Coverage | -4.04 |
Financial Efficiency
Return on equity (ROE) is -181.75% and return on invested capital (ROIC) is -19.06%.
Return on Equity (ROE) | -181.75% |
Return on Assets (ROA) | -13.30% |
Return on Invested Capital (ROIC) | -19.06% |
Return on Capital Employed (ROCE) | -48.32% |
Revenue Per Employee | 2.05M |
Profits Per Employee | -14.11M |
Employee Count | 9 |
Asset Turnover | 0.09 |
Inventory Turnover | 2.52 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.21% in the last 52 weeks. The beta is 0.34, so OSL:OBSRV's price volatility has been lower than the market average.
Beta (5Y) | 0.34 |
52-Week Price Change | -73.21% |
50-Day Moving Average | 3.90 |
200-Day Moving Average | 5.43 |
Relative Strength Index (RSI) | 29.14 |
Average Volume (20 Days) | 25,926 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:OBSRV had revenue of NOK 18.48 million and -126.97 million in losses. Loss per share was -8.32.
Revenue | 18.48M |
Gross Profit | 3.07M |
Operating Income | -42.78M |
Pretax Income | -126.97M |
Net Income | -126.97M |
EBITDA | 39.76M |
EBIT | -42.78M |
Loss Per Share | -8.32 |
Balance Sheet
The company has 1.98 million in cash and 86.16 million in debt, giving a net cash position of -84.18 million or -4.37 per share.
Cash & Cash Equivalents | 1.98M |
Total Debt | 86.16M |
Net Cash | -84.18M |
Net Cash Per Share | -4.37 |
Equity (Book Value) | 24.11M |
Book Value Per Share | 1.25 |
Working Capital | -48.18M |
Cash Flow
In the last 12 months, operating cash flow was -30.68 million and capital expenditures -1.84 million, giving a free cash flow of -32.52 million.
Operating Cash Flow | -30.68M |
Capital Expenditures | -1.84M |
Free Cash Flow | -32.52M |
FCF Per Share | -1.69 |
Margins
Gross Margin | 16.63% |
Operating Margin | -231.46% |
Pretax Margin | -686.93% |
Profit Margin | n/a |
EBITDA Margin | 215.13% |
EBIT Margin | -231.46% |
FCF Margin | n/a |
Dividends & Yields
OSL:OBSRV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -297.36% |
Shareholder Yield | -297.36% |
Earnings Yield | -391.14% |
FCF Yield | -100.18% |
Stock Splits
The last stock split was on January 14, 2025. It was a reverse split with a ratio of 0.0666666667.
Last Split Date | Jan 14, 2025 |
Split Type | Reverse |
Split Ratio | 0.0666666667 |
Scores
OSL:OBSRV has an Altman Z-Score of -4.08. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.08 |
Piotroski F-Score | n/a |